Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus

NCT00004795 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

190

Enrollment

NIH

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: dehydroepiandrosterone

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]